Work

SWOG 0514: A phase II study of sorafenib (BAY 43–9006) as single agent in patients (pts) with unresectable or metastatic gallbladder cancer or cholangiocarcinomas

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.4639

Authors: A. B. El-Khoueiry, C. Rankin, H. J. Lenz, P. Philip, S. E. Rivkin, C. D. Blanke

Institutions: University of Southern California, Oregon Health & Science University, The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2247461220

Cites:

Cited by: 37

Related to: 10